Latest

Case Western Reserve

·October 24, 2024·4 min read

Ozempic Shows Potential in Lowering Alzheimer’s Risk

New research suggests that semaglutide, a popular diabetes and weight-loss drug, may reduce the risk of Alzheimer’s disease in people with type 2 diabetes. The study compared semaglutide to seven other anti-diabetic drugs and found it was linked to a significantly lower risk of developing Alzheimer’s.

Featured Neuroscience Psychology

·June 3, 2024·3 min read

Ozempic May Reduce Alcohol Abuse Risk

Diabetes drugs Wegovy and Ozempic, containing semaglutide, significantly reduce the incidence and recurrence of alcohol-use disorder (AUD). Analyzing health records, researchers observed a 50% to 56% decrease in AUD among patients treated with semaglutide.

Featured Neuroscience

·March 25, 2024·4 min read

Household Chemicals Linked to Brain Health Risks

Certain household chemicals, including those found in personal-care products and furniture, pose a risk to brain health, potentially contributing to diseases like multiple sclerosis and autism. The study reveals that these chemicals damage oligodendrocytes, essential cells for nerve cell protection.

Featured Neuroscience

·August 23, 2023·4 min read

Deciphering Life’s Rhythms: A Universal Key to Oscillations

Life is punctuated by stochastic oscillations, from fireflies to heartbeats. While researchers have managed to interpret some patterns, many have remained unexplained.

Featured Genetics Neurology Neuroscience

·July 24, 2023·4 min read

Protein Suppression: A Promising Route to Slow Alzheimer’s Progression

Researchers have made a breakthrough in Alzheimer's disease (AD) research by identifying a protein that could be key in slowing the disease's progression. They found that the protein Slingshot Homolog-1 (SSH1) inhibits the protective biological activity of Nuclear factor erythroid 2-related factor 2 (Nrf2), which normally defends the brain against oxidative damage.

Featured Neuroscience Psychology

·February 20, 2023·4 min read

Ketamine Could Be Effective Treatment for Cocaine-Use Disorders

Those with cocaine use disorder who were administered ketamine for depression or pain experienced two-to-four times higher remission rate.

Featured Neuroscience Psychology

·September 27, 2022·4 min read

What if Some Stress Actually Protects Your Body?

Study finds the immune system may benefit from a measure of stress.

This shows someone doing a finger prick test

Featured Neurology Neuroscience

·September 24, 2022·4 min read

COVID-19 Associated With Increase in New Diagnoses of Type 1 Diabetes in Youth, by as Much as 72%

Children who contracted COVID-19 are at increased risk of being diagnosed with Type 1 diabetes. Researchers found a 72% increase in new Type 1 diabetes cases in those under 18 who contracted COVID-19.

Featured Neurology Neuroscience

·September 13, 2022·3 min read

Risk for Developing Alzheimer’s Disease Increases by 50-80% In Older Adults Who Caught COVID-19

The risk of developing Alzheimer's disease almost doubled in older people during the one-year period following COVID-19 infection.

Featured Neurology Neuroscience Pain

·June 8, 2022·4 min read

How Does the Brain Process Heat as Pain?

Researchers have uncovered a neural circuit that involves spinal neurons and a signaling pathway that is responsible for how burning pain is sensed.

Brain Cancer Featured Neurology Neuroscience

·May 23, 2022·7 min read

Breakthrough COVID Infections More Likely in Cancer and Alzheimer’s Patients

COVID-19 breakthrough cases that result in severe infection, hospitalization, or death are more likely in those with cancer and Alzheimer's patients.

Featured Neurology Neuroscience Open Neuroscience Articles

·January 9, 2022·4 min read

Findings Open the Way to More Precise Diagnoses and Treatments of Alzheimer’s Disease

Researchers have identified a link between misshapen, fast replicating tau proteins, and accelerated cognitive decline. The findings shed new light on the development and progression of Alzheimer's disease.